Correlation Between Fate Therapeutics and Catalyst Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Fate Therapeutics and Catalyst Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fate Therapeutics and Catalyst Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fate Therapeutics and Catalyst Pharmaceuticals, you can compare the effects of market volatilities on Fate Therapeutics and Catalyst Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fate Therapeutics with a short position of Catalyst Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fate Therapeutics and Catalyst Pharmaceuticals.
Diversification Opportunities for Fate Therapeutics and Catalyst Pharmaceuticals
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Fate and Catalyst is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Fate Therapeutics and Catalyst Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Catalyst Pharmaceuticals and Fate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fate Therapeutics are associated (or correlated) with Catalyst Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Catalyst Pharmaceuticals has no effect on the direction of Fate Therapeutics i.e., Fate Therapeutics and Catalyst Pharmaceuticals go up and down completely randomly.
Pair Corralation between Fate Therapeutics and Catalyst Pharmaceuticals
Given the investment horizon of 90 days Fate Therapeutics is expected to under-perform the Catalyst Pharmaceuticals. In addition to that, Fate Therapeutics is 4.47 times more volatile than Catalyst Pharmaceuticals. It trades about -0.17 of its total potential returns per unit of risk. Catalyst Pharmaceuticals is currently generating about 0.06 per unit of volatility. If you would invest 2,119 in Catalyst Pharmaceuticals on September 25, 2024 and sell it today you would earn a total of 41.00 from holding Catalyst Pharmaceuticals or generate 1.93% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Fate Therapeutics vs. Catalyst Pharmaceuticals
Performance |
Timeline |
Fate Therapeutics |
Catalyst Pharmaceuticals |
Fate Therapeutics and Catalyst Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Fate Therapeutics and Catalyst Pharmaceuticals
The main advantage of trading using opposite Fate Therapeutics and Catalyst Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fate Therapeutics position performs unexpectedly, Catalyst Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Catalyst Pharmaceuticals will offset losses from the drop in Catalyst Pharmaceuticals' long position.Fate Therapeutics vs. Atara Biotherapeutics | Fate Therapeutics vs. Sana Biotechnology | Fate Therapeutics vs. Caribou Biosciences | Fate Therapeutics vs. Arcus Biosciences |
Catalyst Pharmaceuticals vs. Fate Therapeutics | Catalyst Pharmaceuticals vs. Caribou Biosciences | Catalyst Pharmaceuticals vs. Arcus Biosciences | Catalyst Pharmaceuticals vs. Karyopharm Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |